Back to search

Sweden· SE-20220120000092

Wegovy Flex Touch 1 mg Injektionsvätska, lösning i förfylld injektionspenna

A medicinal product, registered in Sweden by Novo Nordisk A/S.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedWegovy Flex Touch 1 mg Injektionsväts…ATC—REGISTER NO.SE-20220120000092PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
Novo Nordisk A/S
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20220120000092

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f07a7250-636c-4f60-86c0-6d07f266236a
GET /v1/drugs/f07a7250-636c-4f60-86c0-6d07f266236a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20220120000092",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20220120000092",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/wegovy-epar-product-information_sv.pdf"
}

See everything about Wegovy.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.